In addition, metformin suppresses TXNIP expression and the TXNIP-NLRP3 interaction, which protects against intestinal ischemia‒reperfusion injury and pyroptosis via the TXNIP-NLRP3-GSDMD pathway71. The gene discussed is NLRP3; the disease is ischemia.